Stay updated with breaking news from Cipla Maroc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The product, Vigabatrin for oral solution, USP 500mg, is used for the treatment of refractory complex partial seizures as adjunctive therapy in patients 2 years of age and older.
Cipla EU acquired an additional 15.1 percent of Cipla Maroc SA, Morocco, which is a JV between Cooper Pharma and Cipla EU.
New Delhi: Cipla (EU) Limited, wholly owned subsidiary of the Company in UK, has agreed to acquire an additional 19.16% stake in Cipla Maroc SA, joint venture and subsidiary of Cipla EU in...
The JV Co. has enabled Cipla to establish a front-end participation in Morocco's pharmaceutical market.